Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

147 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Topotecan and ifosfamide as salvage treatment in advanced ovarian cancer.
Chiara S, Tognoni A, Pastrone I, Tomasello L, Brema F, Di Costanzo G, Folco U, Pronzato P; GONO (Italian Gruppo Oncologico del Nord-Ovest). Chiara S, et al. Among authors: di costanzo g. Gynecol Oncol. 2004 May;93(2):474-8. doi: 10.1016/j.ygyno.2004.01.027. Gynecol Oncol. 2004. PMID: 15099965 Clinical Trial.
Paclitaxel, cisplatin, 5-fluorouracil and radiotherapy in the management of advanced squamous cell carcinoma of the head and neck: a phase II trial.
Merlano M, Russi EG, Numico G, Colantonio I, Garrone O, Pelissero A, Granetto C, Gasco M, Di Costanzo G, Heouaine A, Vigna Taglianti R, Cipolat M. Merlano M, et al. Among authors: di costanzo g. Radiother Oncol. 2005 May;75(2):193-6. doi: 10.1016/j.radonc.2004.11.007. Epub 2004 Dec 9. Radiother Oncol. 2005. PMID: 16086909 Clinical Trial.
Gemcitabine and cisplatin in a concomitant alternating chemoradiotherapy program for locally advanced head-and-neck cancer: a pharmacology-guided schedule.
Numico G, Russi EG, Vitiello R, Sorrentino R, Colantonio I, Cipolat M, Taglianti RV, Pelissero A, Fea E, Granetto C, Di Costanzo G, Gasco M, Garrone O, Occelli M, Merlano M. Numico G, et al. Among authors: di costanzo g. Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):731-7. doi: 10.1016/j.ijrobp.2006.05.059. Int J Radiat Oncol Biol Phys. 2006. PMID: 17011449
Survival prediction and frequency of anticancer treatment in cancer patients hospitalized due to acute conditions. Role of clinical parameters and PaP score.
Numico G, Occelli M, Russi EG, Silvestris N, Pasero R, Fea E, Granetto C, Di Costanzo G, Colantonio I, Gasco M, Garrone O, Polla V, Merlano MC. Numico G, et al. Among authors: di costanzo g. Support Care Cancer. 2011 Nov;19(11):1823-30. doi: 10.1007/s00520-010-1024-5. Epub 2011 May 11. Support Care Cancer. 2011. PMID: 21560032
Variation in gynecological oncology follow-up practice: attributable to cancer centers or to patient characteristics? A Piedmont Regional Oncology Network Study.
Fuso L, Evangelista A, Pagano E, Piovano E, Perotto S, Mazzola S, Bertoldo E, La Porta MR, Rosmino C, Furbatto G, Abate S, Di Costanzo G, Trossarelli G, Baù MG, Carnino F, Gambaro G, Piantanida P, Alabiso O, Galletto L, Zavallone L, Rossi A, Barbero M, Tessa M, Katsaros D, Danese S, Brignolo P, Gorzegno G, Grillo R, Apolone G, Ciccone G. Fuso L, et al. Among authors: di costanzo g. Tumori. 2011 Sep-Oct;97(5):551-8. doi: 10.1177/030089161109700502. Tumori. 2011. PMID: 22158482
147 results